ECM1P1

Across TCGA pan-cancer cohorts, ECM1P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated ECM1P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ECM1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ECM1P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and KICH show a favorable association.

ACC, UVM, and HNSC are the cancer types where ECM1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.114	0.892	<.001	99	view →
UVM	OS	Tertile	All	0.037	0.835	<.001	72	view →
HNSC	DFS	Tertile	III,IV	0.840	0.639	.016	60	view →
THYM	OS	Tertile	All	0.884	0.990	.004	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
CESC	OS	Tertile	IV	0.218	0.631	.010	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	27	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	27	view →
SKCM	DFS	Tertile	IV	0.045	0.477	.005	18	view →
ESCA	DFS	Tertile	All	0.157	0.706	.031	18	view →
LIHC	DFS	Tertile	III,IV	0.045	0.361	<.001	18	view →
PCPG	DFS	Tertile	All	0.500	0.888	.004	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

ECM1P1–ACC (OS)

Open the ACC breakdown →